GlassScriptPhysician profile
Falahat Farooqui
NPI 1447693056
$1,984.01
in general payments reported to CMS, 2019-2025
19 companies · $29.91 in 2025
The $29.91 reported for 2025 was less than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $411 · 2020: $942 · 2021: $275 · 2022: $158 · 2023: $61.20 · 2024: $107 · 2025: $29.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $198.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $307.11 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $250.48 | 2019-2020 | |
| Amgen INC. | $234.22 | 2019-2020 | |
| Amarin Pharma, INC. | $209.91 | 2019-2020 | |
| Alkermes, INC. | $203.03 | 2020-2024 | Aristada, Lybalvi |
| Novo Nordisk INC | $154.01 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Janssen Pharmaceuticals, INC | $117.34 | 2019-2023 | Invega Sustenna |
| Lilly USA, LLC | $74.00 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.81 | 2020 | |
| Merck Sharp & Dohme LLC | $57.77 | 2020 | |
| Esperion Therapeutics, INC. | $53.72 | 2020 | |
| Neurocrine Biosciences, INC. | $51.07 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $47.69 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $36.34 | 2019-2025 | Abilify Maintena, Abilify Asimtufii |
| Pfizer INC. | $33.43 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $29.51 | 2024 | Perseris |
| Owp Pharmaceuticals, INC. | $22.41 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.75 | 2019 | |
| Lundbeck LLC | $17.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Falahat Farooqui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.